Get the Stockscreener App
119.02
0.23%
0.27
After Hours:
119.02
Davita Inc stock is traded at $119.02, with a volume of 1.37M.
It is up +0.23% in the last 24 hours and down -10.42% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$118.75
Open:
$118.34
24h Volume:
1.37M
Relative Volume:
1.67
Market Cap:
$8.51B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
11.08
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-7.87%
1M Performance:
-10.42%
6M Performance:
-15.92%
1Y Performance:
-14.87%
1-Day Range:
$115.39
$119.54
1-Week Range:
$115.39
$130.82
52-Week Range:
$115.39
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
119.02 | 8.38B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
459.68 | 109.23B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
206.49 | 18.33B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.84 | 15.66B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
217.01 | 13.92B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
113.85 | 11.77B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Will DaVita Inc. rebound enough to break evenJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
3 Warren Buffett Stocks to Buy Hand Over Fist in November - The Motley Fool
Zacks Research Downgrades DaVita (NYSE:DVA) to Strong Sell - MarketBeat
Creekmur Asset Management LLC Sells 2,584 Shares of DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Hits New 52-Week Low at USD 117.73 - Markets Mojo
Can DaVita Inc. (TRL) stock retain market dominanceJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Can DaVita Inc. stock beat market expectations this quarterEarnings Risk Summary & Community Consensus Picks - newser.com
Will DaVita Inc. stock outperform tech sector in 20252025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Is DaVita Inc. stock bottoming outRecession Risk & Weekly High Return Forecasts - newser.com
Is DaVita Inc. stock trading at a premium valuationWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Research Alert: CFRA Keeps Hold View On Shares Of Davita Inc. - 富途牛牛
DaVita (NYSE:DVA) Sets New 52-Week Low After Earnings Miss - MarketBeat
Is a relief rally coming for DaVita Inc. holdersMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Custom strategy builders for tracking DaVita Inc.Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsTrade Signal Summary & Weekly High Conviction Trade Ideas - newser.com
How to integrate DaVita Inc. into portfolio analysis toolsTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
DaVita Inc. (DVA) Stock forecasts - Yahoo! Finance UK
DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance - MarketBeat
DaVita Inc. (DVA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - sharewise.com
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges By GuruFocus - Investing.com Canada
Berkshire Hathaway Reduces Stake in DaVita (DVA) by $54.3 Millio - GuruFocus
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita (NYSE:DVA) Posts Earnings Results, Misses Expectations By $0.66 EPS - MarketBeat
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Barclays Adjusts Price Target on DaVita to $143 From $149 - MarketScreener
Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 - MarketScreener
Davita Healthcare Partners stock hits 52-week low at $122.91 - Investing.com
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita price target lowered to $143 from $149 at Barclays - TipRanks
DaVita Inc. (NYSE:DVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Nisa Investment Advisors LLC Cuts Stock Position in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock safe for conservative investors2025 Top Gainers & Trade Opportunity Analysis - newser.com
Sumitomo Mitsui Trust Group Inc. Grows Position in DaVita Inc. $DVA - MarketBeat
Asset Management One Co. Ltd. Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Total debt per share of DaVita Inc. – BER:TRL - TradingView
DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty - The Globe and Mail
DaVita Inc. 3Rd Quarter 2025 Results - 富途牛牛
DaVita Inc. Reports Steady Q3 2025 Performance - TipRanks
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus
DaVita HealthCare: Q3 Earnings Snapshot - Stamford Advocate
DaVita (DVA) Q3 2025 Earnings Call Transcript - Fortune
DaVita’s Profit Misses Mark As Costs And Volume Drop Bite - Finimize
DaVita (DVA) Reaffirms Full-Year Guidance Despite Challenges - GuruFocus
DaVita Delivers Steady Growth But Misses On Earnings - Finimize
Davita shares fall on weak earnings, Berkshire cuts stake further By Investing.com - Investing.com Canada
DaVita Q3 2025 Earnings: Revenue Up 4.8%, EPS Misses EstimatesNews and Statistics - IndexBox
DaVita misses quarterly profit estimates on rising costs, lower volumes - TradingView
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations - TradingView
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):